| Primary |
| Full Blood Count Decreased |
100.0% |
|
| Transfusion-related Acute Lung Injury |
16.7% |
| Aneurysm Ruptured |
8.3% |
| Autoantibody Positive |
8.3% |
| Expired Drug Administered |
8.3% |
| Inadequate Aseptic Technique In Use Of Product |
8.3% |
| Laboratory Test Interference |
8.3% |
| Medication Error |
8.3% |
| No Adverse Event |
8.3% |
| Product Quality Issue |
8.3% |
| Thinking Abnormal |
8.3% |
| Transfusion Reaction |
8.3% |
|
| Secondary |
| Product Used For Unknown Indication |
31.0% |
| Factor Viii Deficiency |
14.7% |
| Operative Haemorrhage |
7.8% |
| Non-small Cell Lung Cancer |
7.0% |
| Delivery |
4.7% |
| Infection |
4.7% |
| Abscess |
3.1% |
| Anaemia |
3.1% |
| Antibiotic Therapy |
3.1% |
| Crohn's Disease |
3.1% |
| Fistula |
3.1% |
| Von Willebrand's Disease |
3.1% |
| Attention Deficit/hyperactivity Disorder |
1.6% |
| Colony Stimulating Factor Therapy |
1.6% |
| Hepatosplenic T-cell Lymphoma |
1.6% |
| Pancytopenia |
1.6% |
| Peritonitis Bacterial |
1.6% |
| Pneumonia Fungal |
1.6% |
| Surgery |
1.6% |
| Colorectal Cancer |
0.8% |
|
| Hepatitis C |
32.4% |
| Hepatitis C Rna Positive |
10.8% |
| Renal Tubular Necrosis |
8.1% |
| Gamma-glutamyltransferase Increased |
5.4% |
| Hepatitis C Virus |
5.4% |
| Hiv Infection |
5.4% |
| Pharmaceutical Product Complaint |
5.4% |
| Pneumonia Fungal |
5.4% |
| Transfusion-related Acute Lung Injury |
5.4% |
| Hepatitis A |
2.7% |
| Hepatitis B Virus Test Positive |
2.7% |
| Hepatitis C Virus Test Positive |
2.7% |
| Hypotony Of Eye |
2.7% |
| Product Quality Issue |
2.7% |
| Therapeutic Response Decreased |
2.7% |
|
| Concomitant |
| Drug Use For Unknown Indication |
17.9% |
| Product Used For Unknown Indication |
15.5% |
| Pancytopenia |
15.3% |
| Neutropenia |
11.0% |
| Multiple Myeloma |
6.3% |
| Anaemia |
5.5% |
| Coronary Artery Bypass |
3.3% |
| Prophylaxis Of Nausea And Vomiting |
3.0% |
| Pain |
2.4% |
| Thrombocytopenia |
2.2% |
| Prophylaxis |
2.1% |
| Nausea |
2.0% |
| Mitral Valve Replacement |
1.9% |
| Myelodysplastic Syndrome |
1.9% |
| Coagulopathy |
1.8% |
| Hypertension |
1.7% |
| Intra-aortic Balloon Placement |
1.7% |
| Cancer Pain |
1.5% |
| Atrial Fibrillation |
1.4% |
| Constipation |
1.3% |
|
| Acute Myeloid Leukaemia |
31.3% |
| Myocardial Ischaemia |
14.3% |
| White Blood Cell Count Decreased |
8.5% |
| Renal Failure |
4.4% |
| Pneumonia |
3.7% |
| Sepsis |
3.7% |
| Injury |
3.3% |
| Upper Gastrointestinal Haemorrhage |
3.3% |
| Fear |
2.9% |
| Pain |
2.9% |
| Death |
2.6% |
| Platelet Count Decreased |
2.6% |
| Vomiting |
2.6% |
| Anaemia |
2.2% |
| Anhedonia |
2.2% |
| Fatigue |
2.2% |
| Myelodysplastic Syndrome |
2.2% |
| Pyrexia |
2.2% |
| Anxiety |
1.5% |
| Haemoglobin Decreased |
1.5% |
|
| Interacting |
| Multiple Myeloma |
53.8% |
| Prophylaxis |
23.1% |
| Thrombosis Prophylaxis |
23.1% |
|
| Acute Myeloid Leukaemia |
100.0% |
|
